
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Phys.
Sec. Accelerator Physics
Volume 13 - 2025 | doi: 10.3389/fphy.2025.1567622
This article is part of the Research Topic Plasma Accelerators: Advances and Challenges View all articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The ELIMAIA-ELIMED beamline, powered by the L3 HAPLS petawatt laser, enables the irradiation of biological samples with intermediate-energy laser-driven protons (LDP) in a multi-shot regime. In the pilot radiobiological experiment, protons with a mean energy of ~ 24 MeV and doses up to ~ 14 mGy per shot, with ~ 4 ns bunch duration, were used to irradiate AG01522 normal human skin fibroblasts. The shortest irradiation time achieved was down to ~ 17 min/Gy, while the mean and peak dose rates reached ~ 1 × 10 -3 and 3.5 × 10 6 Gy/s, respectively. The cells were exposed to doses ranging from ~ 0.4 to 1.5 Gy and analyzed for DNA damage, with double-strand breaks visualized as 53BP1 foci. Despite the differences in shot exposures between the multi-shot LDP and the previous experiments (at other facility) with single-shot LDP, similar DNA damage responses were observed. Results with conventionally accelerated protons align closely with the corresponding single-shot LDP samples. These experimental results were achieved as part of the flagship experiment FLAIM (within the IMPULSE EU-funded project) and serve as an initial demonstration of the ELIMAIA-ELIMED platform's potential for advanced radiobiological research, creating new opportunities for such studies utilizing laser-driven ion sources.
Keywords: Laser-driven protons, Plasma acceleration, radiobiological effects, cell samples irradiation, DNA Damage
Received: 27 Jan 2025; Accepted: 25 Mar 2025.
Copyright: © 2025 Bláha, Prise, Borghesi, Cammarata, Catalano, Chaudhary, Cirrone, Davídková, Doria, Forte, Grepl, Hideghéty, Istokskaia, Manti, McCay, Navrátil, Novák, Pappalardo, Petringa, Russo, Schettino, Schillaci, Szabó, Szotkowski, Tryus, Vannucci, Vondráček, Margarone and Giuffrida. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Pavel Bláha, ELI Beamlines Facility, The Extreme Light Infrastructure ERIC, Dolní Břežany, Czechia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.